Latest Headlines

Latest Headlines

MacuLogix raises $5M to back FDA-cleared early AMD diagnostic

Hummelstown, PA-based startup MacuLogix has raised $5 million to back its FDA-cleared diagnostic test for dark adaptation function disorders, which include age-related macular degeneration and retinitis pigmentosa. The loss of the ability of the eye to adapt to the dark is a very early indicator of those kinds of diseases.

Congress proposes expanded access to mammograms in contradiction of expert recommendation

Reps. Renee Ellmers (R-NC) and Debbie Wasserman Schultz (D-FL) submitted a bill that would overrule a recent U.S. Preventive Services Task Force recommendation against insurance coverage for routine mammograms for women aged 40 to 49 for two years.

Indian diagnostics outfit debuts 'lab-on-cartridge' device for developing countries

As the med tech industry homes in on rapid, point-of-care diagnostics geared toward low-income countries, an Indian diagnostics company is developing a "lab-on-cartridge" device that uses inexpensive technology to quickly scan for a host of diseases and conditions.

GE Healthcare to spend $1B+ in training 2 million global healthcare workers by 2020

GE Healthcare is betting that a more than $1 billion investment over 5 years to train more than 2 million global healthcare providers will pay off. In developed economies, it's looking to ingratiate itself by offering options for improving efficiency as the demand for value-based healthcare looms, while in emerging economies it hopes to establish itself firmly as more people are able to receive basic healthcare.

Cepheid readies for 2016 launch of point-of-care molecular Dx system for use anywhere

Diagnostics are about to be available anywhere the patient is with a new device from Cepheid that it says is the first point-of-care diagnostic device intended for such a broadly defined area of use. The company is unveiling the device at this week's American Association for Clinical Chemistry meeting in Atlanta, GA.

NFL, GE award up to $10M to advance mild traumatic brain injury knowledge, diagnosis

In a continuing effort dubbed the Head Health Initiative,the NFL and partner GE have made awards of $500,000 to the 6 winners of the first of four planned research challenges. This is in addition to $300,000 in grants that it gave to 16 winners in the first round. Between them, they may be awarded a total of up to $10 million.

Abbott resigns itself to low-single-digit medical device sales growth in 2015

Despite strong contributions from fingerstick-free blood glucose monitor Freestyle Libre and mitral valve repair device MitraClip--medical devices remained the worst performing business for Abbott Laboratories last quarter as sales climbed 3.1% on an operational basis to $1.3 billion.

University of Cambridge developing 'pill on a string' to diagnose esophageal cancer

The U.K.'s University of Cambridge touted a study which suggests that its swallowable "pill on a string" has utility because it scrapes off numerous cancer cells from the esophagus as it is withdrawn.

WSJ: Fetal ultrasound procedures are often not medically justified

As fetal-ultrasound procedures continue to increase in the U.S., medical experts are cautioning against running frequent scans with the devices.

EU funds development of a photonic-laser point-of-care cancer Dx device

European researchers from several companies and academic centers are working toward creating a photonic laser-based device that would enable the diagnosis and monitoring of cancer patients in the physician's office. The four-year project is funded via Horizon 2020, the largest and latest EU R&D initiative that's investing a total of almost €80 billion ($86.9 billion) from 2014 to 2020 to stimulate technology transfer.